Form EFFECT CATALYST PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 16, 2026 |
| Accession Number: | 0001193125-26-305103 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bitcoin Price Prediction Points to $80K, SOL Eyes $150 – As This Next 100x Crypto Goes LIVE at $0.0001 [Get in Before the Price Hike]
- ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury
- Giovanni Caforio Appointed Operating Advisor to CD&R Funds
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
